{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:24:37Z","timestamp":1772558677895,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001322","name":"Medical Research Council (MRC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation (NRF)","doi-asserted-by":"publisher","award":["TTK20100813000016115"],"award-info":[{"award-number":["TTK20100813000016115"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004477","name":"Stellenbosch University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jsbmb.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T03:02:00Z","timestamp":1400814120000},"page":"404-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)"],"prefix":"10.1016","volume":"143","author":[{"given":"Donita J.","family":"Africander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"Storbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet P.","family":"Hapgood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jsbmb.2014.05.007_bib0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0897.2010.00930.x","article-title":"Hormonal contraception and HIV-1 transmission","volume":"65","author":"Blish","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QAD.0b013e32834fa13d","article-title":"Hormonal contraception and the risk of HIV acquisition among women in South Africa","volume":"26","author":"Morrison","year":"2012","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.05.007_bib0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0010-7824(90)90093-B","article-title":"Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids","volume":"42","author":"Stanczyk","year":"1990","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.05.007_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.05.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr. Rev."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.05.007_bib0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tips.2004.09.005","article-title":"Not all progestins are the same: implications for usage","volume":"25","author":"Hapgood","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0040","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0045","first-page":"4055","article-title":"Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes","volume":"84","author":"Bamberger","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2004.03.006","article-title":"Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells","volume":"221","author":"Koubovec","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"10 Pt 1","key":"10.1016\/j.jsbmb.2014.05.007_bib0055","first-page":"3763","article-title":"Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds","volume":"9","author":"Ouatas","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2014.05.007_bib0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7","key":"10.1016\/j.jsbmb.2014.05.007_bib0065","first-page":"2557","article-title":"Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer","volume":"40","author":"Teulings","year":"1980","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.05.007_bib0070","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0022-4731(83)90350-3","article-title":"Interaction of medroxyprogesterone acetate with cytosol androgen receptors in the rat hypothalamus and pituitary","volume":"19","author":"Perez-Palacios","year":"1983","journal-title":"J. Steroid Biochem."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.05.007_bib0075","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/0022-4731(83)90371-0","article-title":"Binding of progestagens to receptor proteins in MCF-7 cells","volume":"19","author":"Bergink","year":"1983","journal-title":"J. Steroid Biochem."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.05.007_bib0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00689836","article-title":"Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor","volume":"25","author":"Hackenberg","year":"1993","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(99)00109-4","article-title":"Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells","volume":"154","author":"Bentel","year":"1999","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.05.007_bib0090","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/mend.13.3.0255","article-title":"Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone","volume":"13","author":"Kemppainen","year":"1999","journal-title":"Mol. Endocrinol."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.05.007_bib0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0960-0760(00)00125-4","article-title":"Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives","volume":"74","author":"Schoonen","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.05.007_bib0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0960-0760(00)00093-5","article-title":"Influence of the substitution of 11-methylene, delta(15), and\/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals","volume":"74","author":"Deckers","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2013.02.086","article-title":"Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy","volume":"433","author":"Africander","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2014.05.007_bib0110","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"issue":"Special Issue 1","key":"10.1016\/j.jsbmb.2014.05.007_bib0115","first-page":"157","article-title":"Pharmacology of progestens","volume":"8","author":"Kuhl","year":"2011","journal-title":"J. Reproduktionsmed. Endokrinol."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.05.007_bib0120","doi-asserted-by":"crossref","first-page":"R1036","DOI":"10.1186\/bcr1340","article-title":"The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells","volume":"7","author":"Ghatge","year":"2005","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.05.007_bib0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.contraception.2011.06.006","article-title":"Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract","volume":"84","author":"Africander","year":"2011","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.05.007_bib0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/GME.0b013e3182936ef4","article-title":"Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo","volume":"21","author":"Ochnik","year":"2014","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.05.007_bib0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0303-7207(96)03819-1","article-title":"A and B forms of the androgen receptor are expressed in a variety of human tissues","volume":"120","author":"Wilson","year":"1996","journal-title":"Mol. Cell. Endocrinol."},{"issue":"4854","key":"10.1016\/j.jsbmb.2014.05.007_bib0140","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.05.007_bib0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(89)90237-7","article-title":"Gene regulation by steroid hormones","volume":"56","author":"Beato","year":"1989","journal-title":"Cell"},{"issue":"52","key":"10.1016\/j.jsbmb.2014.05.007_bib0150","doi-asserted-by":"crossref","first-page":"37219","DOI":"10.1074\/jbc.274.52.37219","article-title":"Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain","volume":"274","author":"He","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.jsbmb.2014.05.007_bib0155","doi-asserted-by":"crossref","first-page":"22986","DOI":"10.1074\/jbc.M002807200","article-title":"FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor","volume":"275","author":"He","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.jsbmb.2014.05.007_bib0160","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1074\/jbc.M111975200","article-title":"The FXXLF motif mediates androgen receptor-specific interactions with coregulators","volume":"277","author":"He","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.jsbmb.2014.05.007_bib0165","doi-asserted-by":"crossref","first-page":"29983","DOI":"10.1074\/jbc.270.50.29983","article-title":"Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer","volume":"270","author":"Langley","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/1477-3163.83937","article-title":"Androgen receptor signaling in prostate cancer development and progression","volume":"10","author":"Lonergan","year":"2011","journal-title":"J. Carcinog."},{"issue":"28","key":"10.1016\/j.jsbmb.2014.05.007_bib0175","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1073\/pnas.0408819102","article-title":"The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions","volume":"102","author":"Schaufele","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.05.007_bib0180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/jme.1.01885","article-title":"Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains","volume":"36","author":"Jaaskelainen","year":"2006","journal-title":"J. Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.05.007_bib0185","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2002-021324","article-title":"The use of androgen receptor amino\/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity","volume":"88","author":"Ghali","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0190","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0021-9258(18)48380-9","article-title":"Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones","volume":"267","author":"Kemppainen","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.05.007_bib0195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/me.2003-0189","article-title":"Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor","volume":"18","author":"Song","year":"2004","journal-title":"Mol. Endocrinol."},{"issue":"14","key":"10.1016\/j.jsbmb.2014.05.007_bib0200","doi-asserted-by":"crossref","first-page":"9449","DOI":"10.1074\/jbc.274.14.9449","article-title":"Specific androgen receptor activation by an artificial coactivator","volume":"274","author":"Sui","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1\u20136","key":"10.1016\/j.jsbmb.2014.05.007_bib0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0022-4731(89)90098-8","article-title":"The human androgen receptor: domain structure, genomic organization and regulation of expression","volume":"34","author":"Brinkmann","year":"1989","journal-title":"J. Steroid Biochem."},{"issue":"9","key":"10.1016\/j.jsbmb.2014.05.007_bib0210","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1128\/MCB.19.9.6085","article-title":"The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription","volume":"19","author":"Alen","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.jsbmb.2014.05.007_bib0215","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1073\/pnas.0610814104","article-title":"Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model","volume":"104","author":"Schauwaers","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0220","series-title":"Culture of Animal Cells. A Manual of Basic Technique","author":"Freshney","year":"1987"},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0225","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1172\/JCI117943","article-title":"Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans","volume":"95","author":"Bamberger","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"23","key":"10.1016\/j.jsbmb.2014.05.007_bib0230","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.05.007_bib0235","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2144\/97222pf02","article-title":"Mammalian two-hybrid system: a complementary approach to the yeast two-hybrid system","volume":"22","author":"Luo","year":"1997","journal-title":"Biotechniques"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.05.007_bib0240","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/prot.20921","article-title":"MUSTANG: a multiple structural alignment algorithm","volume":"64","author":"Konagurthu","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0245","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin Drospirenone and its natural counterpart Progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.jsbmb.2014.05.007_bib0255","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/bi961775g","article-title":"Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor","volume":"36","author":"Doesburg","year":"1997","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.jsbmb.2014.05.007_bib0260","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1096\/fj.06-7518com","article-title":"Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer","volume":"21","author":"Birrell","year":"2007","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.05.007_bib0265","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1110\/ps.051905906","article-title":"Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity","volume":"15","author":"de Jesus-Tran","year":"2006","journal-title":"Protein Sci."},{"issue":"12","key":"10.1016\/j.jsbmb.2014.05.007_bib0270","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1074\/jbc.M109.085779","article-title":"Identification of SRC3\/AIB1 as a preferred coactivator for hormone-activated androgen receptor","volume":"285","author":"Zhou","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.05.007_bib0275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molcel.2004.09.036","article-title":"Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance","volume":"16","author":"He","year":"2004","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.jsbmb.2014.05.007_bib0280","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2004-0033","article-title":"Tetrahydrogestrinone is a potent androgen and progestin","volume":"89","author":"Death","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.05.007_bib0285","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/er.2011-1033","article-title":"Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation","volume":"33","author":"Kumar","year":"2012","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.05.007_bib0290","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.mce.2011.03.026","article-title":"Structural features discriminate androgen receptor N\/C terminal and coactivator interactions","volume":"348","author":"Askew","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0295","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0002-9378(79)90715-4","article-title":"Pharmacokinetics of norethindrone acetate in women","volume":"135","author":"Singh","year":"1979","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0300","series-title":"Treatment of the Postmenopausal Woman: Basic and Clinical Aspects","article-title":"Structure-function relationships, pharmacokinetics, and potency or orally and parentally administered progestogens intervention","author":"Stanczyk","year":"2007"},{"issue":"7","key":"10.1016\/j.jsbmb.2014.05.007_bib0305","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/endo.141.7.7549","article-title":"1alpha,25-Dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms","volume":"141","author":"Zhao","year":"2000","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.05.007_bib0310","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"issue":"39","key":"10.1016\/j.jsbmb.2014.05.007_bib0315","doi-asserted-by":"crossref","first-page":"24151","DOI":"10.1074\/jbc.271.39.24151","article-title":"Mutual transcriptional interference between RelA and androgen receptor","volume":"271","author":"Palvimo","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.05.007_bib0320","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1172\/JCI117995","article-title":"Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor","volume":"95","author":"Bellido","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0325","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mce.2008.10.008","article-title":"Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction","volume":"299","author":"Ronacher","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0330","series-title":"An investigation of the interactions of the androgen receptor with a non-steroidal compound and two synthetic progestins","author":"Tanner","year":"2002"},{"key":"10.1016\/j.jsbmb.2014.05.007_bib0335","series-title":"Androgen Action in Prostate Cancer","author":"Tindall","year":"2009"},{"issue":"5925","key":"10.1016\/j.jsbmb.2014.05.007_bib0340","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.1164265","article-title":"DNA binding site sequence directs glucocorticoid receptor structure and activity","volume":"324","author":"Meijsing","year":"2009","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.jsbmb.2014.05.007_bib0345","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/MCB.00151-12","article-title":"Evidence for DNA-binding domain\u2013ligand-binding domain communications in the androgen receptor","volume":"32","author":"Helsen","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.05.007_bib0350","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/BC.2005.009","article-title":"GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor","volume":"386","author":"Shen","year":"2005","journal-title":"Biol. Chem."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.05.007_bib0355","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1210\/me.2005-0298","article-title":"A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin","volume":"20","author":"Li","year":"2006","journal-title":"Mol. Endocrinol."},{"issue":"9","key":"10.1016\/j.jsbmb.2014.05.007_bib0360","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/endo.142.9.8401","article-title":"A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha","volume":"142","author":"Larrea","year":"2001","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.05.007_bib0365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0039-128X(02)00112-5","article-title":"Receptor profiling and endocrine interactions of tibolone","volume":"68","author":"de Gooyer","year":"2003","journal-title":"Steroids"},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2014.05.007_bib0370","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.maturitas.2004.02.012","article-title":"Tissue-selectivity: the mechanism of action of tibolone","volume":"48","author":"Kloosterboer","year":"2004","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.05.007_bib0375","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1210\/jcem-53-1-58","article-title":"Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma","volume":"53","author":"Dunn","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.05.007_bib0380","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0022-4731(78)90631-3","article-title":"A radioimmunoassay for serum medroxyprogesterone acetate","volume":"9","author":"Shrimanker","year":"1978","journal-title":"J. Steroid Biochem."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.05.007_bib0385","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0010-7824(74)90130-9","article-title":"Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera)","volume":"10","author":"Kirton","year":"1974","journal-title":"Contraception"},{"issue":"1C","key":"10.1016\/j.jsbmb.2014.05.007_bib0390","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0022-4731(83)90017-1","article-title":"Variability of pharmacokinetic parameters for contraceptive steroids","volume":"19","author":"Fotherby","year":"1983","journal-title":"J. Steroid Biochem."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076014001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076014001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:48:26Z","timestamp":1760744906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076014001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":78,"alternative-id":["S0960076014001095"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.05.007","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}